We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$3.83M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$3M
3
TECK icon
Teck Resources
TECK
+$2.87M
4
MODV
ModivCare
MODV
+$2.67M
5
G icon
Genpact
G
+$2.6M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.07M
2
CHS
Chicos FAS, Inc.
CHS
+$2.68M
3
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$2.45M
4
CXT icon
Crane NXT
CXT
+$2.44M
5
ATCO
Atlas Corp.
ATCO
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMTX icon
1126
Aemetis
AMTX
$124M
$160K 0.02%
+32,552
New +$285K
FLEX icon
1127
Flex
FLEX
$44.8B
$160K 0.02%
14,679
-20,522
-58% -$254K
DAN icon
1128
Dana Inc
DAN
$3.06B
$158K 0.02%
+11,205
New +$174K
HLX icon
1129
Helix Energy Solutions
HLX
$1.41B
$158K 0.02%
51,074
+38,045
+292% +$165K
CELL
1130
DELISTED
PhenomeX Inc. Common Stock
CELL
$156K 0.02%
31,464
+7,425
+31% +$38.9K
EXTN
1131
DELISTED
Exterran Corporation
EXTN
$156K 0.02%
36,189
-11,696
-24% -$70.8K
IMVT icon
1132
Immunovant
IMVT
$8.25B
$155K 0.02%
+39,817
New +$172K
SGFY
1133
DELISTED
Signify Health, Inc.
SGFY
$155K 0.02%
11,214
-16,744
-60% -$236K
AQB icon
1134
AquaBounty Technologies
AQB
$6.02M
$154K 0.02%
4,503
-2,606
-37% -$79.6K
CLOV icon
1135
Clover Health Investments
CLOV
$2.51B
$154K 0.02%
72,032
+32,080
+80% +$85.3K
MRAM icon
1136
Everspin Technologies
MRAM
$405M
$154K 0.02%
+29,304
New +$189K
NKTR icon
1137
Nektar Therapeutics
NKTR
$2.58B
$154K 0.02%
+2,695
New +$170K
ORC
1138
Orchid Island Capital
ORC
$1.31B
$153K 0.02%
+10,756
New +$160K
VIPS icon
1139
Vipshop
VIPS
$7.53B
$152K 0.02%
+15,379
New +$135K
QNST icon
1140
QuinStreet
QNST
$1.21B
$151K 0.02%
+15,005
New +$158K
SNCR
1141
DELISTED
Synchronoss Technologies
SNCR
$151K 0.02%
14,628
+4,533
+45% +$57.4K
WBD icon
1142
Warner Bros
WBD
$67.1B
$151K 0.02%
11,270
-2,692
-19% -$49.9K
ZYNE
1143
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$151K 0.02%
132,405
-18,509
-12% -$23.6K
AEHR icon
1144
Aehr Test Systems
AEHR
$3.36B
$150K 0.02%
19,951
-15,315
-43% -$127K
XRX icon
1145
Xerox
XRX
$425M
$150K 0.02%
10,091
-12,940
-56% -$229K
DOYU
1146
DouYu International Holdings
DOYU
$142M
$148K 0.02%
12,353
+10,241
+485% +$157K
ASXC
1147
DELISTED
Asensus Surgical, Inc.
ASXC
$148K 0.02%
371,747
+151,068
+68% +$67.4K
NOVN
1148
DELISTED
Novan, Inc. Common Stock
NOVN
$148K 0.02%
63,306
-63,815
-50% -$176K
SPI
1149
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$148K 0.02%
+85,300
New +$182K
AM icon
1150
Antero Midstream
AM
$10.1B
$147K 0.02%
+16,193
New +$168K
44 45
46
47 48

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.